Latest News about ACLX
Recent news which mentions ACLX
Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock
October 27, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
October 27, 2022
From Benzinga
From Benzinga
From Benzinga
63 Biggest Movers From Yesterday
June 17, 2022
From Benzinga
From Benzinga
Mid-Day Market Update: Dow Tumbles 700 points; Advent Technologies Shares Spike Higher
June 16, 2022
From Benzinga
37 Stocks Moving In Thursday's Mid-Day Session
June 16, 2022
From Benzinga
From Benzinga
82 Biggest Movers From Yesterday
June 15, 2022
From Benzinga
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
June 14, 2022
From Benzinga
91 Biggest Movers From Friday
June 13, 2022
From Benzinga
ASCO 2022: Surprising News in Cancer Research
June 10, 2022
From Motley Fool
69 Biggest Movers From Yesterday
June 10, 2022
From Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 09, 2022
From Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
June 08, 2022
From Benzinga
From Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
From Benzinga
From Benzinga
70 Biggest Movers From Friday
May 31, 2022
From Benzinga
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
May 27, 2022
From MarketWatch
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 17, 2022
From Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
From Benzinga
From Benzinga
Arcellx Doses First Patient in Phase 1 study of ACLX-001 in Relapsed or Refractory Multiple Myeloma
May 10, 2022
Tickers
ACLX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.